Adial Pharmaceuticals Inc.
ADIL | NASDAQ
$4.40
-$0.46 (-9.47%)
At close: Sep 21, 2026, 4:00 PM ET
$4.48
+$0.08 (+1.82%)
After-hours:
Sep 21, 2026, 7:30 PM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -57.8M | -7.77M | -7.98M | -8.05M | -8.45M | -8.95M | -13.2M | -13.03M | -12.19M | -11.24M | -7M | -7.96M | -9.73M | -11.45M | -12.12M | -15.08M | -16.29M | -17.5M | -19.42M | -17.06M | -16.08M | -13.45M |
Depreciation & Amortization | 283 | 565 | 565 | 564 | 565 | 565 | 565 | 565 | 564 | 564 | 564 | 15.97K | 31.09K | 31.09K | 45.66K | 46.5K | 43.52K | 57.35K | 55.11K | 38.86K | 26.72K | 12.89K |
Stock-Based Compensation | 600.37K | 587.37K | 676.2K | 688.37K | 729.29K | 807.57K | 796.83K | 616.63K | 696.74K | 494.36K | 727.95K | 1.46M | 1.75M | 1.75M | 2.27M | 2.42M | 3.06M | 3.9M | 4.24M | 3.73M | 3.22M | 2.77M |
Other Working Capital | -2.03M | 306.68K | 157.14K | 154.35K | 580.52K | 445.46K | 215.13K | 103.62K | -457.3K | -720.34K | -460.27K | -71.35K | -236.16K | -235.34K | -961.47K | -488.61K | -435.07K | 583.19K | 1.82M | 854.94K | 1.89M | 1.58M |
Other Non-Cash Items | 46.51M | 397.01K | 342.13K | 372.56K | 326.66K | 450.4K | 5.09M | 5.37M | 5.34M | 5.55M | 136.18K | -648.16K | -723.16K | -798.37K | -183.53K | 1.54M | 1.89M | 1.57M | 1.71M | 313.59K | 39.07K | 679 |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -437.09K | 266.21K | 465.67K | 368.45K | 910.85K | 809.69K | 386.14K | 356.24K | -233.86K | -941.91K | -669.62K | -200.89K | -680.97K | -518.69K | -1.2M | -736.2K | -631.84K | 370.73K | 1.46M | 791.82K | 1.93M | 2.02M |
Operating Cash Flow | -11.13M | -6.52M | -6.49M | -6.62M | -6.48M | -6.88M | -6.92M | -6.69M | -6.39M | -6.13M | -6.81M | -7.34M | -9.35M | -10.99M | -11.19M | -11.81M | -11.93M | -11.6M | -11.95M | -12.19M | -10.87M | -8.65M |
Capital Expenditures | -1 | -1 | -1 | 3 | n/a | n/a | n/a | 1.22M | 1.22M | 3.12M | 3.12M | 1.89M | 1.89M | 1 | 1 | 1 | 1 | -33.73K | -64.61K | -64.61K | -64.61K | -30.87K |
Cash Acquisitions | 5.28M | n/a | 150K | 150K | 150K | 150K | n/a | 350K | 350K | 1.15M | 1.15M | 800K | 800K | n/a | n/a | n/a | n/a | n/a | 30.59K | 30.59K | 30.59K | 30.59K |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 350K | 350K | 350K | 350K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -350K | -350K | -350K |
Investing Cash Flow | 5.28M | n/a | 150K | 150K | 150K | 150K | n/a | 350K | 700K | 1.5M | 1.5M | 1.15M | 800K | n/a | n/a | n/a | n/a | -33.73K | -34.02K | -384.02K | -384.02K | -350.29K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.66K | -1.66K | -1.66K | -1.66K | n/a | n/a | n/a | 455K | 455K | 455K | 1.89M | 1.44M | 1.89M | 1.89M |
Financial Cash Flow | 28.65M | 8.74M | 8.47M | 5.87M | 8.96M | 4.07M | 7.85M | 11.23M | 7.76M | 7.35M | 4.13M | 748.34K | 609.67K | 611.48K | 9.13M | 10.38M | 15.88M | 18.69M | 13.64M | 12.39M | 7.84M | 9.69M |
Net Cash Flow | 22.8M | 2.22M | 2.13M | -598.06K | 2.63M | -2.66M | 923.44K | 4.89M | 2.07M | 2.71M | -1.17M | -5.44M | -7.94M | -10.38M | -2.06M | -1.43M | 3.95M | 7.05M | 1.66M | -184.95K | -3.41M | 686.28K |
Free Cash Flow | -11.13M | -6.52M | -6.49M | -6.62M | -6.48M | -6.88M | -6.92M | -5.47M | -5.17M | -3.02M | -3.69M | -5.44M | -7.45M | -10.99M | -11.19M | -11.81M | -11.93M | -11.64M | -12.01M | -12.26M | -10.93M | -8.68M |
Adj. Free Cash Flow | -11.73M | -7.11M | -7.17M | -7.31M | -7.21M | -7.69M | -7.72M | -6.09M | -5.86M | -3.51M | -4.42M | -6.9M | -9.2M | -12.74M | -13.46M | -14.23M | -14.99M | -15.54M | -16.25M | -15.98M | -14.15M | -11.45M |
Maintenance CapEx | -7 | -7 | -7 | -3 | n/a | n/a | n/a | -141 | -141 | -282 | -282 | -141 | -141 | -1 | -1 | -1 | -1 | -13.97K | -26.44K | -26.44K | -26.44K | -12.47K |
Growth CapEx | 6 | 6 | 6 | 6 | n/a | n/a | n/a | 1.22M | 1.22M | 3.12M | 3.12M | 1.89M | 1.89M | 2 | 2 | 2 | 2 | -19.76K | -38.17K | -38.17K | -38.17K | -18.4K |
Owner Earnings | -11.13M | -6.52M | -6.49M | -6.62M | -6.48M | -6.88M | -6.92M | -6.69M | -6.39M | -6.13M | -6.81M | -7.34M | -9.35M | -10.99M | -11.19M | -11.81M | -11.93M | -11.62M | -11.98M | -12.22M | -10.9M | -8.66M |
Add to Watchlist
Select watchlists to add or remove ADIL